SII's free Covishield supply to govt: First 8 mn doses set for dispatch

Since the launch of the anti-Covid vaccination drive, SII has so far provided 170 crore doses of Covishield to the government

Covishield, Covid-19 vaccine
The Health Ministry has issued a consignee list for the supply of 80 lakh doses of Covishield which will be supplied by the company Saturday, an official source said.
Press Trust of India New Delhi
1 min read Last Updated : Jan 14 2023 | 6:36 PM IST

Amid a rise in Covid cases in some countries, Serum Institute of India has started supply of Covishield to the Centre free of cost with the first lot of 80 lakh doses set to be dispatched from Saturday, official sources said.

Since the launch of the anti-Covid vaccination drive, SII has so far provided 170 crore doses of Covishield to the government.

According to an official source, Prakash Kumar Singh, Director Government and Regulatory Affairs at Serum Institute of India, had written to Union Health Ministry mentioning that the Pune-based firm will provide two crore doses of Covishield vaccine worth Rs 410 crore to the Government of India free of cost.

The Health Ministry has issued a consignee list for the supply of 80 lakh doses of Covishield which will be supplied by the company Saturday, an official source said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Serum Institute of IndiaCoronavirus Vaccinecentral government

First Published: Jan 14 2023 | 6:36 PM IST

Next Story